EGFR and non-small cell lung carcinoma: The most common mechanism of acquired resistance is a secondary mutation at exon 20, T790M gatekeeper mutation, occurring in approximately 50% of the NSCLC patients harboring EGFR mutations with acquired resistance to the TKIs (Gazdar, 2009).